Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.88 EUR | -0.81% | +0.83% | +15.64% |
04-26 | Agronomics investee raises additional EUR8 million | AN |
04-26 | Agronomics' Portfolio Company Raises Additional EUR8 Million for New Protein Product | MT |
Strengths
- Thanks to a sound financial situation, the firm has significant leeway for investment.
- Over the last twelve months, the sales forecast has been frequently revised upwards.
- Growth remains a strong point in this company. In their sales forecast, analysts sound optimistic with regard to sales prospects.
- For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.
- The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
Weaknesses
- The company's earnings growth outlook lacks momentum and is a weakness.
- With an expected P/E ratio at 54.67 and 70.29 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
- The company's "enterprise value to sales" ratio is among the highest in the world.
- For the last few months, analysts have been revising downwards their earnings forecast.
- Most analysts agree on a negative opinion with regard to the stock. Indeed, the average consensus issues recommendations to underperform or sell.
- The overall consensus opinion of analysts has deteriorated sharply over the past four months.
- Over the past twelve months, analysts' opinions have been revised negatively.
Ratings chart - Surperformance
Sector: Investment Management & Fund Operators
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+15.64% | 29.52M | - | ||
+2.10% | 36.06B | B | ||
+14.98% | 35.6B | B | ||
0.00% | 18.31B | - | - | |
+3.45% | 5.36B | - | C | |
+4.58% | 3.14B | - | B- | |
+10.36% | 2.87B | D+ | ||
+19.40% | 2.82B | C- | ||
-16.55% | 2.29B | C+ | ||
+4.02% | 1.24B | - | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- SPRING Stock
- Ratings Springvest Oyj